• About
  • Subscribe
  • Advertise
  • Contact
Wednesday, March 11, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Uncategorized

Federal election: PBS script savings regardless of who’s elected

by Myles Hume
May 2, 2022
in Local, News, Uncategorized
Reading Time: 3 mins read
A A
Optometry Australia is advocating that optometrists be allowed to administer some medicines.

Optometry Australia is advocating that optometrists be allowed to administer some medicines.

Share on FacebookShare on Twitter

Both sides of the political divide are promising to slash the maximum price Australians pay for a PBS script, if elected to govern at the 21 May election, in a move set to benefit thousands of patients with eye disease.

In what would be an Australian-first reduction in the price of government-subsidised medications, from 1 January 2023 the Liberal government’s election promise would see the maximum price Australians pay for Pharmaceutical Benefits Scheme (PBS) medicines (PBS General Co-payment) drop from $42.50 to $32.50, a 24% saving.

Meanwhile, Labor will reduce the maximum co-payment even further, from $42.50 to a maximum of $30, a reduction of 29%.

The script savings would flow through to patients requiring PBS medications for eye disease, including anti-VEGF injections which are among the most heavily subsidised treatments in Australia, costing the government more than $610 million annually.

Under a Liberal government, the policy would mean those taking one medication a month could save $120 a year, or those taking two medications a month could save $240 a year. It would culminate in an annual $150 million hip-pocket saving for around 19 million Australians without a concession card, reducing script costs to 2008 levels.

Labor said its policy would save Australians more than $190 million in out-of-pocket costs. A person taking one medication a month could save $150 a year, with those taking two medications a month saving up to $300 each year.

Prime Minister Mr Scott Morrison said the government’s economic plan would deliver cost of living relief to millions of Australians who will save hundreds of dollars every year on the cost of essential and life-saving medications.

“This is the single most significant change to the cost of and access to medications since the PBS was introduced more than 70 years ago,” he said.

“There is a clear choice at this election. Australians can vote for a stronger economy under the Coalition, who always delivers affordable medication and cost of living relief, or a weak economy under Labor, who stopped listing medicines on the PBS in 2011 because they could not manage the economy.”

Labor leader Mr Anthony Albanese said his government would strengthen Medicare and the PBS.

“Cost of living pressures are real. Everything is going up under the Morrison Government. These changes to the PBS are necessary because we need to make sure that Australians can afford the medications they need,” he said.

More reading

Anti-VEGF becomes most expensive drug on PBS

What’s in the 2022-23 Federal Budget for the eye health sector?

Beovu AMD therapy now listed on the PBS

Tags: federal electionharmaceutical Benefits SchemeLaborliberalmedicationPBSPBS scriptprescription

Related Posts

The cost of intravitreal eye injections to manage macular degeneration has long been a concern. Image: Rose Makin/stock.adobe.com.

MDFA welcomes Gov stand-down on eye injection changes

by Staff Writer
March 11, 2026

Macular Disease Foundation Australia (MDFA) says it is is heartened by the Federal Government’s decision not to proceed with the...

The new guidelines for handling sexual misconduct were published in December 2025. Image: Antonioguillem/stock.adobe.com.

OA expresses support, concern on sex misconduct changes

by Rob Mitchell
March 11, 2026

Optometry Australia has supported new Australian Health Practitioners Regulation Agency (Ahpra) guidance on healthcare workers found guilty of sexual misconduct...

Image: Andrii Yalanskyi/stock.adobe.com.

People on the move – March 2026

by Staff Writer
March 10, 2026

Welcome to People on the move – March 2026, Insight’s monthly bulletin to keep the Australian ophthalmic sector updated on new appointments and...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited